Sponsor:
Massachusetts General Hospital
Code:
NCT05124392
Conditions
CJD (Creutzfeldt Jakob Disease)
Prion Diseases
GSS
FFI
Familial Fatal Insomnia
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
CJD (Creutzfeldt Jakob Disease)
Prion Diseases
GSS
FFI
Familial Fatal Insomnia
Study ID
NCT05124392
Start date
Dec 1, 2017
Status verified date
Aug, 2026
Completion date
Jun 1, 2027
Anticipated
Primary completion date
Jun 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
150 participants
Anticipated
Arms
Individuals with a family history of Prion disease
Primary outcome measure
Central contacts
Alison McManus, DNP
ajmcmanus@mgh.harvard.eduLocations
Alzheimer's Clinical and Translational Research Unit
Recruiting
Charlestown, Massachusetts, United States, 02129
Contacts
Principal Investigator:
Steven E Arnold, MD
Sponsor
Massachusetts General Hospital
Last update posted
Aug 13, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-03. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2026-08-13. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.